Stephen A. Goldman

686 total citations
20 papers, 407 citations indexed

About

Stephen A. Goldman is a scholar working on Toxicology, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Stephen A. Goldman has authored 20 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Toxicology, 4 papers in Economics and Econometrics and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Stephen A. Goldman's work include Biomedical Ethics and Regulation (3 papers), Pharmaceutical industry and healthcare (3 papers) and Pharmacovigilance and Adverse Drug Reactions (3 papers). Stephen A. Goldman is often cited by papers focused on Biomedical Ethics and Regulation (3 papers), Pharmaceutical industry and healthcare (3 papers) and Pharmacovigilance and Adverse Drug Reactions (3 papers). Stephen A. Goldman collaborates with scholars based in United States, Spain and Japan. Stephen A. Goldman's co-authors include Lynne L. Johnson, Paul J. Cannon, Melvin B. Weiss, Michihito Deguchi, Shobha Potlakayala, Ramesh Katam, Sairam Rudrabhatla, Rubin Bressler, Elliot G. Brown and Olivera Marjanovic and has published in prestigious journals such as PLoS ONE, The American Journal of Medicine and Clinical Therapeutics.

In The Last Decade

Stephen A. Goldman

18 papers receiving 372 citations

Peers

Stephen A. Goldman

TOXIC

CCM

PPCH

Lateef M. Khan Saudi Arabia

Kurt Anseeuw Belgium

Johanna Strandell Sweden

Taofikat B. Agbabiaka United Kingdom

Giuseppe Vighi Italy

He Sun China

E. Pérez Spain

Mohammad Ismail Pakistan

Tanya Azaz‐Livshits Israel

Mukta N. Chowta India

Lateef M. Khan Saudi Arabia

Stephen A. Goldman

142 ×1.3

TOXIC

49 ×0.7

CCM

91 ×1.4

PPCH

20 ×0.4

54 ×1.1

Citations per year, relative to Stephen A. Goldman Stephen A. Goldman (= 1×) peers Lateef M. Khan

Countries citing papers authored by Stephen A. Goldman

Since Specialization

Citations

This map shows the geographic impact of Stephen A. Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen A. Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen A. Goldman more than expected).

Fields of papers citing papers by Stephen A. Goldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen A. Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen A. Goldman. The network helps show where Stephen A. Goldman may publish in the future.

Co-authorship network of co-authors of Stephen A. Goldman

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen A. Goldman. A scholar is included among the top collaborators of Stephen A. Goldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen A. Goldman. Stephen A. Goldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goldman, Stephen A., Gordon Vrdoljak, Weihong Guo, et al.. (2021). The analytical landscape of cannabis compliance testing. Journal of Liquid Chromatography & Related Technologies. 44(9-10). 403–420. 5 indexed citations

Goldman, Stephen A., et al.. (2019). Improving Patient Care.

Deguchi, Michihito, et al.. (2019). Enhanced tolerance of industrial hemp (Cannabis sativa L.) plants on abandoned mine land soil leads to overexpression of cannabinoids. PLoS ONE. 14(8). e0221570–e0221570. 63 indexed citations

Goldman, Stephen A.. (2016). Causality Assessment in Premarketing Drug Clinical Trials: Regulatory Evolution in the USA and Ongoing Concerns. Drug Safety. 39(10). 895–901.

Goldman, Stephen A.. (2007). U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty.. PubMed. 62(3). 513–28. 2 indexed citations

Goldman, Stephen A.. (2006). Auditing Safety-Related Processes and Procedures: Lessons Learned for Global Compliance and Quality. Drug Information Journal. 40(2). 165–175. 1 indexed citations

Goldman, Stephen A.. (2004). Communication of Medical Product Risk. Drug Safety. 27(8). 519–534. 28 indexed citations

Brown, Elliot G. & Stephen A. Goldman. (2004). Foreword. Drug Safety. 27(8). 489–490. 4 indexed citations

Goldman, Stephen A.. (2002). Adverse Event Reporting and Standardized Medical Terminologies: Strengths and Limitations. Drug Information Journal. 36(2). 439–444. 9 indexed citations

10.

Michotte, Alex, et al.. (2001). Frontotemporal dementia : a clinicopathological study. VUBIR (Vrije Universiteit Brussel). 1 indexed citations

11.

Goldman, Stephen A.. (1999). Use of a Mail‐Out Continuing Education Article to Teach Health Professionals about Drug‐Induced Disease. The Journal of Clinical Pharmacology. 39(11). 1126–1135. 2 indexed citations

12.

Goldman, Stephen A.. (1998). Limitations and strengths of spontaneous reports data. Clinical Therapeutics. 20. C40–C44. 192 indexed citations

13.

Goldman, Stephen A., et al.. (1998). Improving Patient Care: by reporting problems with medical devices. 3(2). 20–30. 3 indexed citations

14.

Goldman, Stephen A., et al.. (1996). Teaching Healthcare Professionals About Drug‐Induced Disease: An Innovative Clinical Therapeutic Approach. The Journal of Clinical Pharmacology. 36(5). 386–396. 4 indexed citations

15.

Goldman, Stephen A.. (1996). Lithium and Neuroleptics in Combination: Is There Enhancement of Neurotoxicity Leading to Permanent Sequelae?. The Journal of Clinical Pharmacology. 36(10). 951–962. 16 indexed citations

16.

Matalon, Andre, et al.. (1994). [The Kibbutz physician: family medicine theory in practice].. PubMed. 127(3-4). 70–4. 1 indexed citations

17.

Bressler, Rubin & Stephen A. Goldman. (1993). A role of fatty acid oxidation in cardiac hypertrophy.. PubMed. 4(3). 133–42. 8 indexed citations

18.

Goldman, Stephen A.. (1992). Organic Delusional Disorder on a Consultation-Liaison Psychiatry Service. Psychosomatics. 33(3). 343–352. 3 indexed citations

19.

Goldman, Stephen A.. (1989). Brain Imaging: Applications in Psychiatry. Psychosomatics. 30(4). 457–458. 1 indexed citations

20.

Goldman, Stephen A., et al.. (1980). Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure. The American Journal of Medicine. 68(1). 36–42. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact